Måndag 5 Maj | 09:52:48 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2020-02-12 - X-dag kvartalsutdelning ORI 4.3126
2019-11-14 - X-dag kvartalsutdelning ORI 4.3126
2019-11-07 - Kvartalsrapport 2019-Q3
2019-09-30 - Extra Bolagsstämma 2019
2019-08-14 - X-dag kvartalsutdelning ORI 4.3126
2019-08-08 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag kvartalsutdelning ORI 4.3126
2019-05-09 - Årsstämma
2019-05-09 - Kvartalsrapport 2019-Q1
2019-02-14 - X-dag kvartalsutdelning ORI 4.1922
2019-02-14 - Bokslutskommuniké 2018
2018-11-14 - X-dag kvartalsutdelning ORI 4.1004
2018-11-07 - Kvartalsrapport 2018-Q3
2018-08-14 - X-dag kvartalsutdelning ORI 4.174
2018-08-07 - Kvartalsrapport 2018-Q2
2018-05-08 - X-dag kvartalsutdelning ORI 14.7594
2018-05-04 - Årsstämma
2018-05-04 - Kvartalsrapport 2018-Q1
2018-02-15 - Bokslutskommuniké 2017
2018-02-14 - X-dag kvartalsutdelning ORI 2.47
2017-11-14 - X-dag kvartalsutdelning ORI 2.4392
2017-11-08 - Kvartalsrapport 2017-Q3
2017-08-17 - Kvartalsrapport 2017-Q2
2017-08-14 - X-dag kvartalsutdelning ORI 2.395
2017-05-12 - X-dag kvartalsutdelning ORI 7.2357
2017-05-10 - Kvartalsrapport 2017-Q1
2017-05-09 - Årsstämma
2017-02-16 - Kapitalmarknadsdag 2017
2017-02-16 - Bokslutskommuniké 2016
2017-02-14 - X-dag kvartalsutdelning ORI 2.4363
2016-11-14 - X-dag kvartalsutdelning ORI 1.9791
2016-11-11 - Kvartalsrapport 2016-Q3
2016-08-16 - Kvartalsrapport 2016-Q2
2016-05-18 - X-dag kvartalsutdelning ORI 0
2016-05-18 - Kvartalsrapport 2016-Q1
2016-05-17 - Årsstämma
2016-05-17 - Kvartalsrapport 2016-Q1
2016-02-18 - Bokslutskommuniké 2015
2015-11-12 - Kvartalsrapport 2015-Q3
2015-08-13 - Kvartalsrapport 2015-Q2
2015-05-20 - X-dag kvartalsutdelning ORI 0
2015-05-19 - Årsstämma
2015-05-08 - Kvartalsrapport 2015-Q1
2015-02-11 - Bokslutskommuniké 2014
2014-11-04 - Analytiker möte 2014
2014-11-04 - Kvartalsrapport 2014-Q3
2014-08-14 - Kvartalsrapport 2014-Q2
2014-05-20 - X-dag kvartalsutdelning ORI 2.2533
2014-05-19 - Extra Bolagsstämma 2014
2014-05-19 - Årsstämma
2014-05-07 - Kvartalsrapport 2014-Q1
2014-02-14 - Bokslutskommuniké 2013
2013-11-12 - Analytiker möte 2013
2013-11-12 - Kvartalsrapport 2013-Q3
2013-08-15 - Kvartalsrapport 2013-Q2
2013-05-22 - X-dag ordinarie utdelning ORI 15.05 SEK
2013-05-21 - Extra Bolagsstämma 2013
2013-05-21 - Årsstämma
2013-04-25 - Kvartalsrapport 2013-Q1
2013-02-14 - Bokslutskommuniké 2012
2012-12-19 - Extra Bolagsstämma 2012
2012-10-25 - Kvartalsrapport 2012-Q3
2012-08-14 - Kvartalsrapport 2012-Q2
2012-05-22 - X-dag ordinarie utdelning ORI 15.77 SEK
2012-05-21 - Årsstämma
2012-04-27 - Kvartalsrapport 2012-Q1
2012-02-17 - Bokslutskommuniké 2011
2011-11-10 - Kvartalsrapport 2011-Q3
2011-08-10 - Kvartalsrapport 2011-Q2
2011-05-20 - X-dag ordinarie utdelning ORI 13.08 SEK
2011-05-19 - Extra Bolagsstämma 2011
2011-05-19 - Årsstämma
2011-05-04 - Kvartalsrapport 2011-Q1
2011-02-16 - Bokslutskommuniké 2010
2010-10-26 - Kvartalsrapport 2010-Q3
2010-08-11 - Kvartalsrapport 2010-Q2
2010-05-20 - X-dag ordinarie utdelning ORI 12.80 SEK
2010-05-19 - Årsstämma
2010-04-21 - Kvartalsrapport 2010-Q1
2010-02-10 - Bokslutskommuniké 2009
2009-10-23 - Kvartalsrapport 2009-Q3
2009-08-12 - Kvartalsrapport 2009-Q2
2009-05-20 - X-dag ordinarie utdelning ORI 13.65 SEK
2009-05-19 - Årsstämma
2009-04-23 - Kvartalsrapport 2009-Q1

Beskrivning

LandSchweiz
SektorHandel & varor
IndustriDetaljhandel
Oriflame är ett internationellt, direktförsäljande kosmetikföretag grundat i Sverige 1967. Bolaget bedriver egen forskning och utveckling och har ett produktutbud av svenska skönhetsprodukter inspirerade av naturen. Detta inkluderar hudvård, nutrition, make-up, parfymer och hårvård. Oriflame marknadsförs via oberoende Oriflame-konsulter och är en schweizisk bolagskoncern noterad på Nasdaq Stockholm.
2019-01-18 08:17:05

Oriflame is updating the market with preliminary unaudited key figures for the fourth quarter 2018, showing a shift in the geographical mix and maintaining a stable underlying profitability. Asia & Turkey recorded a sales decline during the quarter, while an improved sales momentum was seen in Latin America, Europe & Africa and CIS. Given the company's financial position and profitability, the Board of Directors has the intention to propose to the 2019 AGM a total dividend in line with last year's ordinary dividend.

Preliminary and unaudited key figures Q4 2018 (Q4 2017, FY 2018)
  • Local currency sales increased by 1% with a euro sales decrease of 3% to €370m (€380.1m, FY €1,319m).
  • Operating margin amounted to 13.5% (14.8%, FY 11.3%), negatively impacted by around 140 bps from currencies, and operating profit amounted to €50m (€56.3m, FY €149m).
  • Net profit amounted to €33 (€35.8m, FY €96m) and diluted EPS to €0.57 (€0.62, FY €1.68).
  • The net debt at hedged values/EBITDA ratio amounted to 0.25 compared to -0.02 in 2017.
Preliminary and unaudited geographical sales mix Q4 2018
  • Latin America: local currency sales increased by 6% (euro sales increase of 5%).
  • Europe & Africa: local currency sales increased by 7% (euro sales increase of 7%).
  • CIS: local currency sales increased by 5% (euro sales decrease of 2%).
  • Asia & Turkey: local currency sales decreased by 8% (euro sales decrease of 13%).

Dividend proposal
Based on the preliminary unaudited results and financial position, and in line with the company's dividend policy, the Board of Directors has the intention to propose to the 2019 AGM a total dividend of €1.60 (to be compared with 2018 AGM €1.60 ordinary dividend + €1.00 extra ordinary dividend).

The company remains in a closed period until the full year-end report will be published on February 14, 2019 according to the company's financial calendar and policy.

For information, please contact:
Gabriel Bennet, Chief Financial Officer +41 798 263 769
Nathalie Redmo, Sr. Manager Investor Relations, +41 799 220 173

This information is inside information that Oriflame Holding AG is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:05 CET on January 18, 2019.

*IFRS - Clarifying information
The preliminary unaudited figures and comments above are excluding the impact of IFRS 15, IFRS 16 and related accounting alignments. The numbers are fully comparable with the 2017 reported figures.

Founded in 1967, Oriflame is a beauty company selling direct in more than 60 countries. Its wide portfolio of Swedish, nature-inspired, innovative beauty products is marketed through approximately 3 million independent Oriflame Consultants, generating annual sales of around €1.4 billion. Respect for people and nature underlies Oriflame's operating principles and is reflected in its social and environmental policies. Oriflame supports numerous charities worldwide and is a Co-founder of the World Childhood Foundation. Oriflame is a Swiss company group listed on the Nasdaq Stockholm Exchange. For more information about Oriflame, please visit www.oriflame.com.